Zdrowie i gospodarka · 06/10/1997

FDA Announces Opportunity for Hearing on Proposal to Revoke Knickerbocker Biologicals' Licenses

The Food and Drug Administration (FDA) is seeking public input on a proposal to revoke the licenses of Knickerbocker Biologicals, Inc. for manufacturing certain blood products, due to the facility's closure and inability to conduct an inspection.